120 related articles for article (PubMed ID: 8536642)
1. Acute nuclear actions of growth hormone (GH): cycloheximide inhibits inducible activator protein-1 activity, but does not block GH-regulated signal transducer and activator of transcription activation or gene expression.
Gronowski AM; Le Stunff C; Rotwein P
Endocrinology; 1996 Jan; 137(1):55-64. PubMed ID: 8536642
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone stimulates interferon regulatory factor-1 gene expression in the liver.
Le Stunff C; Rotwein P
Endocrinology; 1998 Mar; 139(3):859-66. PubMed ID: 9492014
[TBL] [Abstract][Full Text] [Related]
3. Rapid changes in gene expression after in vivo growth hormone treatment.
Gronowski AM; Rotwein P
Endocrinology; 1995 Nov; 136(11):4741-8. PubMed ID: 7588201
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of growth hormone action in models of inflammation.
Bergad PL; Schwarzenberg SJ; Humbert JT; Morrison M; Amarasinghe S; Towle HC; Berry SA
Am J Physiol Cell Physiol; 2000 Dec; 279(6):C1906-17. PubMed ID: 11078706
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone rapidly activates rat serine protease inhibitor 2.1 gene transcription and induces a DNA-binding activity distinct from those of Stat1, -3, and -4.
Thomas MJ; Gronowski AM; Berry SA; Bergad PL; Rotwein P
Mol Cell Biol; 1995 Jan; 15(1):12-8. PubMed ID: 7528325
[TBL] [Abstract][Full Text] [Related]
6. Rapid changes in nuclear protein tyrosine phosphorylation after growth hormone treatment in vivo. Identification of phosphorylated mitogen-activated protein kinase and STAT91.
Gronowski AM; Rotwein P
J Biol Chem; 1994 Mar; 269(11):7874-8. PubMed ID: 7510676
[TBL] [Abstract][Full Text] [Related]
7. Early responses of trans-activating factors to growth hormone in preadipocytes: differential regulation of CCAAT enhancer-binding protein-beta (C/EBP beta) and C/EBP delta.
Clarkson RW; Chen CM; Harrison S; Wells C; Muscat GE; Waters MJ
Mol Endocrinol; 1995 Jan; 9(1):108-20. PubMed ID: 7760844
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone (GH)-stimulated insulin-like growth factor I gene expression is mediated by a tyrosine phosphorylation pathway depending on C-terminal region of human GH receptor in human GH receptor-expressing Ba/F3 cells.
Yoshizato H; Tanaka M; Nakai N; Nakao N; Nakashima K
Endocrinology; 2004 Jan; 145(1):214-20. PubMed ID: 14551225
[TBL] [Abstract][Full Text] [Related]
9. Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding.
Chen Y; Sun D; Krishnamurthy VM; Rabkin R
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1856-62. PubMed ID: 17327369
[TBL] [Abstract][Full Text] [Related]
10. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA
Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967
[TBL] [Abstract][Full Text] [Related]
11. Modulation and lack of cross-talk between signal transducer and activator of transcription 5 and Suppressor of cytokine signaling-3 in insulin and growth hormone signaling in 3T3-L1 adipocytes.
Story DJ; Stephens JM
Obesity (Silver Spring); 2006 Aug; 14(8):1303-11. PubMed ID: 16988072
[TBL] [Abstract][Full Text] [Related]
12. Contrasting acute in vivo nuclear actions of growth hormone and prolactin.
Le Stunff C; Gronowski AM; Rotwein P
Mol Cell Endocrinol; 1996 Aug; 121(2):109-17. PubMed ID: 8892312
[TBL] [Abstract][Full Text] [Related]
13. In vivo growth hormone treatment rapidly stimulates the tyrosine phosphorylation and activation of Stat3.
Gronowski AM; Zhong Z; Wen Z; Thomas MJ; Darnell JE; Rotwein P
Mol Endocrinol; 1995 Feb; 9(2):171-7. PubMed ID: 7776967
[TBL] [Abstract][Full Text] [Related]
14. Acute control of insulin-like growth factor-I gene transcription by growth hormone through Stat5b.
Woelfle J; Billiard J; Rotwein P
J Biol Chem; 2003 Jun; 278(25):22696-702. PubMed ID: 12682066
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha decreases insulin-like growth factor-I messenger ribonucleic acid expression in C2C12 myoblasts via a Jun N-terminal kinase pathway.
Frost RA; Nystrom GJ; Lang CH
Endocrinology; 2003 May; 144(5):1770-9. PubMed ID: 12697682
[TBL] [Abstract][Full Text] [Related]
16. GH inhibits interferon-gamma-induced signal transducer and activator of transcription-1 activation and expression of the inducible isoform of nitric oxide synthase in INS-1 cells.
Sekine N; Fukumoto S; Ishikawa T; Okazaki T; Fujita T
Endocrinology; 2001 Sep; 142(9):3909-16. PubMed ID: 11517169
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 inhibits growth hormone-mediated gene expression in hepatocytes.
Ahmed TA; Buzzelli MD; Lang CH; Capen JB; Shumate ML; Navaratnarajah M; Nagarajan M; Cooney RN
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1793-803. PubMed ID: 17395896
[TBL] [Abstract][Full Text] [Related]
18. Termination of growth hormone pulse-induced STAT5b signaling.
Gebert CA; Park SH; Waxman DJ
Mol Endocrinol; 1999 Jan; 13(1):38-56. PubMed ID: 9892011
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3.
Denson LA; Held MA; Menon RK; Frank SJ; Parlow AF; Arnold DL
Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G646-54. PubMed ID: 12519742
[TBL] [Abstract][Full Text] [Related]
20. Regulation of IGF-I mRNA and signal transducers and activators of transcription-3 and -5 (Stat-3 and -5) by GH in C2C12 myoblasts.
Frost RA; Nystrom GJ; Lang CH
Endocrinology; 2002 Feb; 143(2):492-503. PubMed ID: 11796503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
